Biotech: Page 39

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    A Changing Market Environment Requires New PLM Strategies

    In a market environment that is increasingly value-based, the industry must begin to review its product life-cycle management (PLM) strategy and prepare for more effective ways to cope with the evolving challenges when it comes to pipeline maintenance. For example, companies need to start impleme...

    By Robin Robinson • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Taking Innovation to a New Level Ulrich Betz, Ph.D., Director at Merck Serono Portfolio Development and Head of the Department Center of Innovation, talks about fostering innovation and entrepreneurial thinking within the company. PV: What is the Merck Serono internal Innospire innovation program...

    By Ulrich Betz • Sept. 27, 2011
  • drug shopping cart Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Commercialization, marketing and social media

    As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Greg IRACE Anne WHITAKER Sanofi Shifts U.S. Leadership Sanofi has named Greg Irace senior VP, global services. Mr. Irace leads the global information systems function and is responsible for shared support functions across all Sanofi businesses in North America. He also plays a...

    By PharmaVoice Team • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New electronic and web-based applications, sites, and technologies POR Provides Real-Time Engagement Between Doctors and Brands Trend: Driven by physician access issues and shrinking sales forces, pharma brand marketers are looking for ways to use nonpersonal and digital promotion more effectivel...

    By PharmaVoice Team • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Awards… » Agile Recognized by New Jersey Group Agile Therapeutics has been named Life Sciences Company of the Year by the New Jersey Technology Council, a nonprofit ­organization supporting growth in N.J.’s various technology ­sectors, including health sciences. » Ogilvy Wins Spanish Awards Ogilv...

    By PharmaVoice Team • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Letter from the Editor Nurturing the Life Cycle The challenges facing the industry — declining R&D productivity, a changing healthcare landscape, and increasing competition from generics, among others — have been well-publicized. In the past, cost-cutting measures, outcomes, and trial managem...

    By Taren Grom • Sept. 27, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Decoding Data Dynamics

    By Carolyn Gretton The shift in life-sciences development toward more personalized therapeutics is driving a need for proactive clinical data management (CDM) strategies that take into account the volume and complexity of information emerging from today’s clinical trials. Data management is being...

    By Carolyn Gretton • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Hola Mexico: Pharma Drawn to U.S. Neighbor

    By Kim Ribbin Growing health coverage, high medical standards, a ­motivated patient population, and huge geographic ­advantages make Mexico an appealing market for the ­pharmaceutical industry. With a population of around 110 million people and a growing focus on healthcare, Mexico has fast becom...

    By Kim Ribbink • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Beyond Stem Cells

    By Denise Myshko It may seem like science fiction: a trachea grown from stem cells and implanted into a human being. But it’s not; this is an actual account of the power of stem cells and regenerative medicine. The 36-year-old patient, who had been suffering from late-stage tracheal cancer, recei...

    By Denise Myshko • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Mentoring: More Crucial Than Ever

    By Robin Robinson With the industry in constant flux, industry leaders say mentoring is key for career advancement. Declining budgets, the emergence of small innovative startups with fewer resources, busy schedules, and an ever-changing work environment are a few of the factors that make mentorin...

    By Robin Robinson • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Making Strategic Alliances Work Wa’el Hashad, VP, U.S. Cardiovascular and Metabolic Disorders, at Boehringer Ingelheim Pharmaceuticals, talks about how an alliance with Lilly helped to bring a new product to the diabetes market. PV: What challenges are encountered when ­developing diabetes produc...

    By PharmaVoice Team • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Dr. Tomas BOCANEGRA Pozen Appoints Development VP Pozen, a pharmaceutical company committed to developing medicines that transform lives, has named Tomas Bocanegra, M.D., executive VP of develo...

    By PharmaVoice Team • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Tools of the Trade

    New electronic and web-based applications, sites, and technologies By Carolyn Gretton Clinical Force Acquisition Strengthens Medidata’s CTMS Offerings Trends: E-clinical solutions providers continue to bolster their clinical trial management solutions (CTMS) offerings as demand surges amid increa...

    By Carolyn Gretton • Aug. 29, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2011 PharmaVOICE 100 - Who's on the List by Section

    The Commanders & Chiefs Frank Baldino Jr., Ph.D. Cephalon Inc. Donna Beardsworth. Beardsworth Group Calep A. (Joe) Boyd III MCS Healthcare Public Relations Randall Carpenter, M.D. Seaside Therapeutics N. Anthony Coles, M.D. Onyx Pharmaceuticals B. Reid Connolly evoke interaction Donna Cryer C...

    By PharmaVoice Team • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    The Commanders & Chiefs

    Frank Baldino Jr., Ph.D.    Cephalon Inc. Donna Beardsworth.    Beardsworth Group Calep A. (Joe) Boyd III    MCS Healthcare Public Relations Randall Carpenter, M.D.     Seaside Therapeutics N. Anthony Coles, M.D.    Onyx Pharmaceuticals B. Reid Connolly    evoke interaction Donna Cryer    CryerHe...

    By PharmaVoice Team • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Damian BRAGA Sanofi Pasteur Consolidates ­Commercial Operations Leadership Sanofi Pasteur, the vaccines division of global healthcare company Sanofi, has tapped U.S. President Damian Braga as s...

    By Carolyn Gretton • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    On the Calendar

    August 6-8 BIT’s 1st Annual World Congress of Molecular & Cell Biology Beijing International Convention Center, Beijing BIT Life Sciences, http://www.bitlifesciences.com/cmcb2011/ August 8-9 Development and Validation of ­Bioanalytical Assays for Biologics: Quantitation (PK) and Immunogenicit...

    By PharmaVoice Team • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    What’s New New healthcare-related products, services, and companies By Carolyn Gretton PPD Expands Product Development Consulting Services Trend: Quick growth in sectors like biosimilars and adaptive trial design have life-sciences ­companies clamoring for consultants with specific knowledge of t...

    By Carolyn Gretton • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2011 PharmaVOICE 100 - Who's on the List by Company

    Acorda Therapeutics Andrew Blight, Ph.D. ACT Biotech Inc. Ali Fattaey, Ph.D. Acucela Inc. Ryo Kubota, M.D., Ph.D. Alliance Healthcare Information LLC Mary Anne Greenberg Almac Group Sir Allen McClay The Avoca Group Inc. Patricia Leuchten AXON US Mario Nacinovich Beardsworth Group Donna Beardswort...

    By PharmaVoice Team • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Taking Inspiration to the Next Level This is our favorite issue of the year, and we hope it’s yours too. It has been a joy and a privilege to have had a chance to get to know this year’s PharmaVOICE 100. They certainly illustrate what it means to think bigger, do more, and lead with passion and i...

    By Taren Grom • July 26, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    SHOWCASE FEATURE: A Changing Rhythm

    According to Barbara Wirostko, M.D., chief medical officer for Altheos, the question of whether a product candidate will be reimbursed by government and third-party payers is now surfacing in the earliest stages of discovery. “Because there are now issues around who is going to reimburse and who ...

    By PharmaVoice Team • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Educating the Scientists of the Future

    High-quality science education is critical for the success of pharmaceutical and biotechnology companies, not only to meet the need for scientists in the future but also to foster scientific ­literacy. Education reform is a hot-button issue for the nation in general and the pharmaceutical industr...

    By Denise Myshko • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    DIA Preview

    New Tools, Services, and Products Designed to Improve Drug Development This special Drug Information Association section highlights the new and innovative products being offered by ­companies exhibiting at the upcoming 2011 DIA — 47th Annual Meeting in Chicago. (Note: briefs are listed alphabetic...

    By PharmaVoice Team • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Combating Drug Resistance Roger Pomerantz, M.D., Senior VP and Head of Infectious Disease Research at Merck, talks about why antimicrobial resistance is a major global concern. PV: How big of a problem is antimicrobial ­resistance? Pomerantz: For the first time since the antibiotic era started in...

    By PharmaVoice Team • May 24, 2011
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Dr. Janet HAMMOND Roche Strengthens Translational Medicine Leadership Roche has appointed Janet Hammond, M.D., Ph.D., VP, translational medicine – virology in pharmaceutical research and early development (pRED). Dr. Hammond joins Roche from Valeant Pharmaceuticals Internation...

    By PharmaVoice Team • May 24, 2011